Clinical ResearchN-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study
Under a Creative Commons license
open access
Central Illustration
Key Words
clinical outcomes
heart failure
heart failure with reduced ejection fraction
natriuretic peptide
Abbreviations and Acronyms
CI
confidence interval
CVD
cardiovascular death
HF
heart failure
HFH
heart failure hospitalization
HRrEF
heart failure with reduced ejection fraction
HR
hazard ratio
MAGGIC
Meta-Analysis Global Group in Chronic Heart Failure
NT-proBNP
N-terminal pro-B-type natriuretic peptide
Cited by (0)
Scott Solomon, MD, served as Guest Editor for this paper.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Heart Failure author instructions page.
© 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.